Get complete Patent Opposition Report for Sandoz

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Sandoz

Explore patent oppositions filed by Sandoz against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3897646Pharmaceutical Composition For The Treatment Of Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSFeb 7, 2025
EP4054620Glp-1 Receptor Agonists In DementiaNOVO NORDISKFeb 7, 2025
EP3335707Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUPJan 17, 2025
EP3328416Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 12, 2024
EP3474820Glp-1 Compositions And Uses ThereofNOVO NORDISKNov 7, 2024
EP3007695Compositions And Methods For Treating AnemiaAKEBIA THERAPEUTICSNov 6, 2024
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 10, 2024
EP3478286Methods Of Treating Ovarian CancerTESAROSep 18, 2024
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 12, 2024
EP3815688Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHASep 6, 2024

Explore Sandoz's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3373914Jun 1, 2022Storage Stable Composition Comprising Rifaximin Alpha1
EP3536311Dec 22, 2021Storage Stable Composition Comprising Rifaximin Alpha1
EP3434265Jul 7, 2021Pharmaceutical Composition Containing Rifaximin Alpha & Delta3
EP3390358Sep 23, 2020Crystalline Eravacycline Bis-Hydrochloride1
EP3416627Apr 22, 2020Oral Dosage Form Comprising Rifaximin In Form Beta1
EP2785702Jan 22, 2020Crystalline Dapagliflozin Hydrate1
EP2975050May 29, 2019Quantification Of Misfolded Tnfr2:Fc1
EP2977372May 8, 2019Polymorphs Of Febuxostat1
EP2988733Mar 27, 2019Pharmaceutical Composition Containing Crystalline Macitentan1
EP3003277Feb 20, 2019Process For The Preparation Of A Pharmaceutical Composition Comprising Rivaroxaban1